These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 25817468
21. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing. Berry JL, Lewis L, Zolfaghari E, Green S, Le BHA, Lee TC, Murphree AL, Kim JW, Jubran R. Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867 [No Abstract] [Full Text] [Related]
22. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. Ueda T, Koga Y, Yoshikawa H, Tanabe M, Yamana K, Oba U, Nakashima K, Ono H, Ichimura T, Hasegawa S, Kato W, Kobayashi T, Nakayama H, Sakai Y, Yoshitake T, Ohga S, Oda Y, Suzuki S, Sonoda KH, Ohga S. BMC Pediatr; 2020 Jan 28; 20(1):37. PubMed ID: 31992242 [Abstract] [Full Text] [Related]
23. Prenatal versus Postnatal Screening for Familial Retinoblastoma. Soliman SE, Dimaras H, Khetan V, Gardiner JA, Chan HS, Héon E, Gallie BL. Ophthalmology; 2016 Dec 28; 123(12):2610-2617. PubMed ID: 27712844 [Abstract] [Full Text] [Related]
24. Molecular alterations in retinoblastoma beyond RB1. Mendonça V, Evangelista AC, P Matta B, M Moreira MÂ, Faria P, Lucena E, Seuánez HN. Exp Eye Res; 2021 Oct 28; 211():108753. PubMed ID: 34478740 [Abstract] [Full Text] [Related]
25. Bilateral retinoblastoma with one eye manifesting only posterior chamber infiltration and no retinal involvement. Ossandon D, Kastner A, Zanolli M, Solanes F, Pérez V, Repetto G, Benavides F, Shields CL. J AAPOS; 2016 Dec 28; 20(6):548-550.e1. PubMed ID: 27815188 [Abstract] [Full Text] [Related]
26. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Xu L, Shen L, Polski A, Prabakar RK, Shah R, Jubran R, Kim JW, Biegel J, Kuhn P, Cobrinik D, Hicks J, Gai X, Berry JL. Ophthalmic Genet; 2020 Dec 28; 41(6):526-532. PubMed ID: 32799607 [Abstract] [Full Text] [Related]
27. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. Mehyar M, Mosallam M, Tbakhi A, Saab A, Sultan I, Deebajah R, Jaradat I, AlJabari R, Mohammad M, AlNawaiseh I, Al-Hussaini M, Yousef YA. Hematol Oncol Stem Cell Ther; 2020 Sep 28; 13(3):152-159. PubMed ID: 32222358 [Abstract] [Full Text] [Related]
28. Simultaneous diagnosis of unilateral retinoblastoma and contralateral optic pathway glioma in a child with neurofibromatosis type 1. Das A, Ghosh P, Zameer L, Ramprasad VL, Bhaduri A. Pediatr Hematol Oncol; 2019 Mar 28; 36(2):82-85. PubMed ID: 30963792 [No Abstract] [Full Text] [Related]
29. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy. Kim JW. Int Ophthalmol Clin; 2015 Mar 28; 55(1):77-96. PubMed ID: 25436495 [No Abstract] [Full Text] [Related]
30. RB1 gene mutations and genetic spectrum in retinoblastoma cases. Akdeniz Odemis D, Kebudi R, Bayramova J, Kilic Erciyas S, Kuru Turkcan G, Tuncer SB, Sukruoglu Erdogan O, Celik B, Kurt Gultaslar B, Buyukkapu Bay S, Tuncer S, Yazici H. Medicine (Baltimore); 2023 Sep 08; 102(36):e35068. PubMed ID: 37682130 [Abstract] [Full Text] [Related]
32. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma. Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL. Br J Ophthalmol; 2018 Nov 08; 102(11):1597-1601. PubMed ID: 30150278 [Abstract] [Full Text] [Related]
33. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S. Pediatr Blood Cancer; 2008 Mar 08; 50(3):567-72. PubMed ID: 17729249 [Abstract] [Full Text] [Related]
34. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH. Pediatr Blood Cancer; 2007 Sep 08; 49(3):256-60. PubMed ID: 17029248 [Abstract] [Full Text] [Related]
35. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL. J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531 [Abstract] [Full Text] [Related]
36. Late-diagnosis retinoblastoma with germline mosaicism in an 8-year-old. Astudillo PP, Chan HS, Héon E, Gallie BL. J AAPOS; 2014 Oct 01; 18(5):500-2. PubMed ID: 25266839 [Abstract] [Full Text] [Related]
37. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability. Römer T, Temming P, Lohmann DR, Sturm D, von Deimling A, Sellhaus B, Mull M, Kontny U, Moser O. Pediatr Blood Cancer; 2019 May 01; 66(5):e27599. PubMed ID: 30604586 [Abstract] [Full Text] [Related]
38. Spectrum of RB1 mutations in argentine patients: 20-years experience in the molecular diagnosis of retinoblastoma. Ottaviani D, Parma D, Giliberto F, Ferrer M, Fandino A, Davila MT, Chantada G, Szijan I. Ophthalmic Genet; 2013 Dec 01; 34(4):189-98. PubMed ID: 23301675 [Abstract] [Full Text] [Related]